10.06.2025
As part of the Global Pharmaceutical & Society Studies (GPSS) webinar series, Christian Haddad presented the ALTERBIOTIC project and its key research objectives, alongside a thorough conceptualization of the antibiotic innovation crisis. Social science research – and especially perspectives form Science & Technology Studies (STS) — are indispensable to grasp this crisis, as pharmaceutical innovation are not just technical issues to be fixed by technical means, but are embedded in broader social, cultural, economic and institutional regimes and frameworks.
Alongside Christian were fellow speakers Dr Rohit Malpani, senior advisor to the Global Antibiotic Research and Development Partnership (GARDP), and Dr Vasanthi Ramachandran, Vice President of BUGWORKS Research India.
Dr Malpani discussed the discrepancies between framing the AMR crisis as a public health, or as an innovation failure, highlighting the real-world impact of public-private partnerships like GARDP in reshaping the innovation landscape. Meanwhile, Dr Ramachandran provided a glimpse into the research conducted at BUGWORKS – including the use of cutting-edge AI technology to revolutionise drug discovery – reflecting on the pivotal role of small companies in addressing the AMR crisis. Main challenges persist for small companies in the need to diversify funding partners and collaborators.
Leave a Reply